Details of the Drug
General Information of Drug (ID: DMQHTR4)
Drug Name |
1-(4-chlorophenyl)-2-(phenylsulfonyl)ethanone
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
1-(4-Chlorophenyl)-2-(phenylsulfonyl)ethanone; 38488-19-6; CHEMBL238834; 1-(4-chlorophenyl)-2-(phenylsulfonyl)-1-ethanone; 4-Chlorophenacylphenyl sulfone; AC1LBPW5; SCHEMBL10931021; ZINC58239; CTK6G9147; MolPort-002-876-864; KZACHGLUJYSTGQ-UHFFFAOYSA-N; BDBM50212531; CCG-43075; AKOS003310153; MCULE-9299558448; 7H-330S; KS-00001Z91; ST50308734; Ethanone, 1-(4-chlorophenyl)-2-phenylsulfonyl-; 4'-CHLORO-2(PHENYL SULFONYL)ACETOPHENONE; 2-(benzenesulfonyl)-1-(4-chlorophenyl)ethanone; AF-731/00081054
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Small molecular drug
|
||||||||||||||||||||||
Structure | |||||||||||||||||||||||
3D MOL | 2D MOL | ||||||||||||||||||||||
#Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 294.8 | |||||||||||||||||||||
Logarithm of the Partition Coefficient (xlogp) | 3.2 | ||||||||||||||||||||||
Rotatable Bond Count (rotbonds) | 4 | ||||||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 0 | ||||||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 3 | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
The Studied Disease | Discovery agent | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ICD Disease Classification | N.A. | |||||||||||||||||||||||
|
||||||||||||||||||||||||
Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||